Preview Mode Links will not work in preview mode

Clinical Literature Summaries presented by InpharmD™ (S3)

Jan 20, 2022

A double-blind, randomized, placebo-controlled trial conducted to evaluate the efficacy and safety of a 3-day course of remdesivir in high-risk, non-hospitalized patients with COVID-19.


Jan 6, 2022

A single-blind, multicenter, randomized, controlled trial conducted to evaluate the efficacy of financial incentives dependent on continuous smoking abstinence on smoking cessation and birth outcomes among pregnant smokers.